TY - JOUR
KW - Adult
KW - Buprenorphine/administration & dosage/therapeutic use
KW - Drug Combinations
KW - Ethnic Groups
KW - Female
KW - Harm Reduction
KW - Health Services Accessibility
KW - Heroin Dependence/drug therapy/ethnology
KW - Homeless Persons
KW - Humans
KW - Male
KW - Naloxone/administration & dosage/therapeutic use
KW - Narcotic Antagonists/administration & dosage/therapeutic use
KW - Needle-Exchange Programs
KW - New York City/epidemiology
KW - Opiate Substitution Treatment
KW - Patient Acceptance of Health Care/ethnology/statistics & numerical data
KW - Pilot Projects
KW - Social Marginalization
KW - Young Adult
AU - S. Stancliff
AU - H. Joseph
AU - C. Fong
AU - T. Furst
AU - S. D. Comer
AU - P. Roux
A1 - 
AB - The aim of this pilot study was to assess the effectiveness of buprenorphine/naloxone (BUP/NX) among marginalized, opioid-dependent individuals in terms of retention in and cycling into and out of a harm-reduction program. This pilot study enrolled 100 participants and followed them from November 2005 to July 2008. The overall proportion of patients retained in the program at the end of 3, 6, 9, and 12 months was 68%, 63%, 56%, and 42%, respectively. This pilot study demonstrated that BUP/NX could be successfully used to treat marginalized heroin users.
BT - Journal of addictive diseases
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 3
CY - England
DO - 10.1080/10550887.2012.694603
IS - 3
JF - Journal of addictive diseases
N2 - The aim of this pilot study was to assess the effectiveness of buprenorphine/naloxone (BUP/NX) among marginalized, opioid-dependent individuals in terms of retention in and cycling into and out of a harm-reduction program. This pilot study enrolled 100 participants and followed them from November 2005 to July 2008. The overall proportion of patients retained in the program at the end of 3, 6, 9, and 12 months was 68%, 63%, 56%, and 42%, respectively. This pilot study demonstrated that BUP/NX could be successfully used to treat marginalized heroin users.
PP - England
PY - 2012
SN - 1545-0848; 1055-0887
SP - 278
EP - 287
EP - 
T1 - Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations
T2 - Journal of addictive diseases
TI - Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 22873189
U3 - 10.1080/10550887.2012.694603
VL - 31
VO - 1545-0848; 1055-0887
Y1 - 2012
ER -